Recent Decisions of the EPO Boards of Appeal in Biotechnology and Biopharmaceuticals
The most important decisions of the Boards of Appeal in the field of biopharmaceuticals and biotechnology and changes in the Guidelines will be presented. The panelists will discuss, in particular, the consequences of these decisions and changes on patent practice.
- Second medical uses and food
- NGTs and Plant Patentability vs. Plant Breeders Rights
- "Plausibility": the influence of G 2/21 on subsequent case law
- Effectively claiming formal and substantial priority
- Patenting antibodies in the EPO and other jurisdictions
- Deposits and their disclosure
| Veranstaltungs-Code | FB24-139371-61077340 |
Bildungsziel der Schulung:
The most important decisions of the Boards of Appeal in the field of biopharmaceuticals and biotechnology and changes in the Guidelines will be presented. The panelists will discuss, in particular, the consequences of these decisions and changes on patent practice.
-
The panelists offer experience in the field of biopharmaceuticals with one of the most eminent Patent Attorneys practicing exclusively in the field of biotechnology and biopharmaceuticals. Thus, an informed presentation of the decisions with a focus on the impact on practice is guaranteed.
Veranstaltungsort:
Online-Webinar
weitere Orte/Termine
Kursart:
Online-Webinar
Kostenlos Info anfordern
